C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/18 (2006.01) A61K 39/29 (2006.01) A61K 39/39 (2006.01) A61K 45/00 (2006.01)
Patent
CA 2521931
A Hepatitis C virus (HCV) protein such as a non-structured protein 4 (NS4) or a non-structured protein 3 (NS3) or a derivative or fragment or variant or peptide thereof or product of cells activated by the agent is useful in the treatment and/or prophylaxis of an inflammatory and/or an immune-mediated disorder. The agent can also be used as a vaccine adjuvant.
L'invention concerne une protéine du virus de l'hépatite C (VHC) telle qu'une protéine non structurale 4 (NS4), une protéine non structurale 3 (NS3), ou un dérivé, un fragment, un variant ou un peptide de celle-ci, ou un produit cellulaire activé par l'agent décrit, qui conviennent pour le traitement et/ou la prévention d'un trouble inflammatoire ou d'un trouble d'origine immunitaire. Cet agent peut également être utilisé comme adjuvant vaccinal.
Brady Miriam Therese
Mills Kingston Henry Gordon
Moffat & Co.
The Provost Fellows And Scholars Of The College Of The Holy And Undivid Ed T
LandOfFree
Use of hcv proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hcv proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hcv proteins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1953889